Investor/Analyst Meeting
Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General
Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General
Post-script of the conference call of Indian and Overseas Investors held on 12-11-2018 to discuss about unaudited financial results (stand-alone
Intimation that Mr. Sachin Salvi, General Manager-Finance, would be participating at IDFC Securities Annual Investor Conference ‘The Stock called India’